Pharsight Monthly Summary
SEPTEMBER, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
20
drug patents lapsed
Photos
79
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
60 DEGREES PHARMS
 
ABBVIE
 
ASTRAZENECA
 
ATHENA
 
AVADEL CNS
 
AXSOME
 
AXSOME MALTA
 
AZURITY
 
BOEHRINGER INGELHEIM
 
CHIESI
 
CMP DEV LLC
 
DELCATH SYSTEMS INC
 
ESPERION THERAPS INC
 
EYENOVIA
 
GILEAD SCIENCES INC
 
GLAXOSMITHKLINE
 
HERON THERAPS INC
 
HOPE PHARMS
 
INDIVIOR
 
INNOCOLL PHARMS
 
INTRA-CELLULAR
 
IPSEN
 
JANSSEN BIOTECH
 
JAZZ PHARMS INC
 
KARYOPHARM THERAPS
 
MAIA PHARMS INC
 
MALLINCKRODT ARD
 
NEUROCRINE
 
NOVO
 
PF PRISM CV
 
RIGEL PHARMS INC
 
STERISCIENCE
 
TARSUS
 
VERTEX PHARMS INC
 
VIIV HLTHCARE
 
XELLIA PHARMS APS
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XEPI FERRER INTERNACIONAL
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
ACTOPLUS MET XR 8470368 Sep, 2023
ACTOPLUS MET XR 8668931 Sep, 2023
ACTOPLUS MET XR 9060941 Sep, 2023
ALPHAGAN P 8858961 Sep, 2023
HECTOROL 7148211 Sep, 2023
KYNAMRO 7101993 Sep, 2023
LAMICTAL XR 9144547 Sep, 2023
NUZYRA 7326696 Sep, 2023
PROAIR HFA 7105152 Sep, 2023
QUTENZA 10463598 Sep, 2023
QUTENZA 10869827 Sep, 2023
QUTENZA 8263059 Sep, 2023
QUTENZA 8889113 Sep, 2023
RIOMET 6890957 Sep, 2023
SPINRAZA 7101993 Sep, 2023
TEGSEDI 7101993 Sep, 2023
TEMODAR 6987108 Sep, 2023
TYZEKA 7589079 Sep, 2023
TYZEKA 7858594 Sep, 2023
VIBATIV 6635618 Sep, 2023
Newly introduced Drug Patents
Drug Patent Patent expiry
ACTHAR GEL 11752199 Feb, 2041
AKEEGA 11207311 Jul, 2037
AKEEGA 8071579 Aug, 2027
AKEEGA 8143241 Aug, 2027
AKEEGA 8859562 Aug, 2031
APONVIE 11744800 Sep, 2035
ARAKODA 11744828 Dec, 2035
AUVELITY 11752144 Feb, 2043
BIKTARVY 11744802 Nov, 2036
BORTEZOMIB 11752164 Sep, 2042
BOSULIF 11103497*PED Aug, 2034
BOSULIF 7417148*PED Jun, 2026
BOSULIF 7767678*PED May, 2027
BOSULIF 7919625*PED Jun, 2026
BOSULIF RE42376*PED Oct, 2024
BYLVAY 11732006 Nov, 2031
CAPLYTA 11753419 Dec, 2040
CINVANTI 11744800 Sep, 2035
DAPTOMYCIN 11759497 Aug, 2038
DEFITELIO 11746348 Jun, 2032
DOVATO 8129385*PED Apr, 2028
DOVATO 9242986*PED Jun, 2030
FERRIPROX 11723874 Oct, 2038
FOCINVEZ 11065256 Jan, 2039
HEPZATO 10569004 Nov, 2032
INGREZZA 11439629 Oct, 2037
INGREZZA 11654142 Nov, 2038
JARDIANCE 11666590 Apr, 2034
JULUCA 8129385*PED Apr, 2028
JULUCA 9242986*PED Jun, 2030
KALYDECO 11752106 Feb, 2033
LIQREV 11759468 Dec, 2038
LOKELMA 11738044 Oct, 2035
LUMRYZ 11766418 Jul, 2037
MYDCOMBI 10839960 Jul, 2031
MYDCOMBI 11398306 Jul, 2031
NEXLETOL 11760714 Jun, 2040
NEXLIZET 11744816 Mar, 2036
NEXLIZET 11760714 Jun, 2040
NITHIODOTE 11753301 Feb, 2030
NYMALIZE 11759457 Apr, 2038
OJJAARA 8486941 Jan, 2030
OJJAARA 9809559 Jun, 2035
OJJAARA RE48285 Jun, 2035
PERSERIS KIT 11712475 Feb, 2028
QBRELIS 11771733 Nov, 2035
QDOLO 11752103 Sep, 2040
REZLIDHIA 11723905 Nov, 2039
REZLIDHIA 11738018 Jul, 2039
RYBELSUS 11759501 Mar, 2033
RYBELSUS 11759502 Mar, 2033
RYBELSUS 11759503 Mar, 2033
SINCALIDE 11737983 Apr, 2038
SODIUM THIOSULFATE 11753301 Feb, 2030
SOHONOS 10292954 Aug, 2031
SOHONOS 10864194 Jun, 2037
SOHONOS 11622959 Jun, 2037
SOHONOS 9314439 Aug, 2031
SOHONOS 9789074 Aug, 2031
SUNOSI 11753368 Jun, 2026
SUNOSI 11771666 Dec, 2042
SUNOSI 11771667 Dec, 2042
TIVICAY 8129385*PED Apr, 2028
TIVICAY 9242986*PED Jun, 2030
TIVICAY PD 8129385*PED Apr, 2028
TIVICAY PD 9242986*PED Jun, 2030
TRIKAFTA (COPACKAGED) 11752106 Feb, 2033
UBRELVY 11717515 Dec, 2041
WEGOVY 11752198 Aug, 2038
XALKORI 7230098 Aug, 2025
XALKORI 7825137 May, 2027
XALKORI 7858643 Oct, 2029
XALKORI 8217057 Nov, 2029
XALKORI 8785632 Mar, 2025
XARACOLL 11746141 Jan, 2033
XDEMVY 11752137 Dec, 2038
XPOVIO 11746102 Aug, 2035
XPOVIO 11753401 Aug, 2035
ZEJULA 11730725 Jan, 2039
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2023 GreyB Research